4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-031637
Chairman and CEO bought 5,700 shares at an average $1.39 ($7,929)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-05-20 | Purchase | +4,000 | $1.40 | $5,600 | 10,633,793 | D |
| Niihara Yutaka Chairman and CEO | 2020-05-21 | Purchase | +1,700 | $1.37 | $2,329 | 10,635,493 | D |
| Open-market purchases · 5,700 sh · avg $1.39 · $7,929 | |||||||
Loading xslF345X03/doc4.xml…